Systemic thromboembolism in rheumatic heart disease

Area of Science:

• Cardiovascular Pathology
• Rheumatic Heart Disease Research
• Thromboembolic Event Analysis

Background:

• Rheumatic heart disease (RHD) remains a significant cause of acquired heart disease globally.
• Systemic thromboembolism (STE) is a serious complication of RHD, leading to organ damage.
• Autopsy studies provide critical insights into the pathological manifestations of chronic diseases like RHD.

Purpose of the Study:

• To analyze the incidence and patterns of STE in patients with RHD.
• To identify risk factors associated with STE in this patient population.
• To correlate clinical findings with autopsy results regarding STE.

Main Methods:

• Retrospective analysis of autopsy findings from 62 patients diagnosed with rheumatic heart disease.
• Data collection included patient demographics, cardiac status, and evidence of thromboembolic events.
• Statistical review of STE incidence in relation to atrial fibrillation and sinus rhythm.

Main Results:

• Thirteen out of 62 RHD patients (21%) exhibited STE.
• Renal infarction was the most common manifestation (13/13 STE cases), followed by cerebral (2/13) and splenic infarction (1/13).
• Elderly males with atrial fibrillation demonstrated a higher incidence of STE compared to other subgroups.

Conclusions:

• STE is a frequent autopsy finding in RHD patients, primarily manifesting as renal infarction.
• Atrial fibrillation and patient demographics (elderly males) are associated with increased STE risk in RHD.
• Clinical diagnosis of STE in RHD patients is often missed, highlighting the importance of autopsy data.